Atlas Trials

Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC

Clinical trial NCT07052669 · RECRUITING

Trial details

NCT number
NCT07052669
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Locally Advanced Non-Small Cell Lung Cancer
Start date
2025-07-01
Primary completion
2029-06-30
Enrollment
311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.